Related Experiment Video

Updated: Mar 17, 2026

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

3.6K

The Effect of Hemoglobin Levels on Mortality in Pediatric Patients with Severe Traumatic Brain Injury

Kevin F Yee1, Andrew M Walker1, Elaine Gilfoyle2

  • 1Department of Anesthesia, Foothills Medical Centre, University of Calgary, 1403 29 Street NW, Calgary, AB, Canada T2N 2T9.

Canadian Respiratory Journal
|July 23, 2016
PubMed

Insights

In pediatric traumatic brain injury patients, anemia and blood transfusions were not linked to adverse outcomes or mortality. Abusive head trauma and lower Glasgow Coma Scale scores were associated with increased mortality risk.

Area of Science:

  • Pediatric critical care medicine
  • Neuroscience
  • Hematology

Background:

  • Adult traumatic brain injury patients show adverse outcomes with blood transfusions.
  • Pediatric traumatic brain injury patients may have different vascular responses to transfusions.
  • Evidence on blood transfusions and anemia in pediatric traumatic brain injury is limited.

Purpose of the Study:

  • To examine the influence of blood transfusions and anemia on outcomes in pediatric traumatic brain injury.
  • To investigate the association between anemia, blood transfusions, and mortality in severe pediatric TBI patients.

Main Methods:

  • Retrospective cohort analysis of severe pediatric traumatic brain injury (TBI) patients.
  • Included 120 patients with severe TBI.
  • Analyzed associations between blood transfusions, anemia, and patient outcomes using multivariable regression.

Main Results:

  • Forty-three percent of patients received packed red blood cell transfusions.
  • Anemia and packed red blood cell transfusions were not associated with adverse outcomes.
  • Abusive head trauma, increasing PRISM score, and low Glasgow Coma Scale (GCS) were associated with mortality.

Conclusions:

  • No association found between anemia, blood transfusions, and hospital mortality in pediatric TBI patients.
  • Factors like abusive head trauma and initial GCS are significant predictors of mortality.

More Related Videos

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

951
Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury07:21

Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury

Published on: May 27, 2022

3.7K

Related Concept Videos

Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
8.0K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
423
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313